Navigation Links
Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published

the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

Forward-Looking Statement

This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in Amgen's Form 10-K for the year ended December 31, 2005, and in Amgen's periodic reports on Form 10-Q and Form 8-K. Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

No forward-looking statement can be guaranteed and actual results may differ materially from those Amgen projects. In addition, sales of Amgen's products are affected by the availability of reimbursement and the reimbursement policies imposed by third party payors, including governments, private insurance plans and managed care providers, and may be affected by domestic and international trends toward managed care and healthcare cost containment as well as possible U.S. legislation affecting pharmaceutical pricing and reimbursement. Government regulations and reimbursement policies may affect the development, usage and pricing of Amgen's products. In addition, Amgen competes with other companies with respect to some of Amgen's marketed products as well as for the discovery and development of new products. Amgen believes that some of the newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Amgen products may compete against products that have lower prices, established reimbursement, superi
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Human Genome Sciences Announces Positive Final Results Of Phase 2b Trial of Albuferon
2. Positive Final Data from HyCAMP Phase II Trial in Metastatic Colorectal
3. Intarcia Therapeutics Announces Presentation of Final Results From a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference
4. Intarcia Therapeutics Announces Final Results From a Phase 2 Study of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
5. Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
6. Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:4/28/2015)... PLAINSBORO, N.J. , April 28, 2015 /PRNewswire-USNewswire/ ... treatments but they also require more of manufacturers, ... Times , the specialty pharmacy field,s premiere journal, ... Pharmacy (NASP), the only national trade association dedicated ... pharmacy businesses and clinicians to fill this growing ...
(Date:4/28/2015)... , April 28, 2015 Semler Scientific, Inc. ... company that develops, manufactures and markets patented products that ... diseases, today announced that it has received an order ... in the country who offer Medicare Advantage programs. This ... 15 insurance plans who are now customers of Semler. ...
(Date:4/28/2015)... , April 28, 2015  Olympus, a precision technology ... and surgical procedures, among other core businesses, announced today ... Brooklyn Park, MN. The new ... designed to position the company for continued long-term growth ... dedication ceremony took place on April 27 and was ...
Breaking Medicine Technology:Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 2Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 3Specialty Pharmacy Times Partners With National Association of Specialty Pharmacy to Improve Care for Patients 4Semler Adds Top Insurance Plan to Customer List 2Semler Adds Top Insurance Plan to Customer List 3Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 2Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 3Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 4
(Date:4/28/2015)... New and more complex medicines offer ... payers, pharmacists and patients. Now Specialty Pharmacy Times, ... with the National Association of Specialty Pharmacy (NASP), ... this developing field to better equip pharmacy businesses ... “This partnership creates a powerful platform for getting ...
(Date:4/28/2015)... Hellen Chen, who is a bestselling author and ... to a study conducted by Washington University, between ... has increased by 20% while the number of unfaithful husbands ... report released this year from the Journal of ... or both spouses admit to infidelity, either physical or emotional ...
(Date:4/28/2015)... Angeles, CA (PRWEB) April 28, 2015 ... is 2.9 out of 5, indicating a medium ... power means buyers and suppliers have equal power during ... of substitutes. Rather than purchasing a health insurance policy ... Cigna Corporation or Humana), buyers can choose to self-fund ...
(Date:4/28/2015)... Memphis, Tennessee (PRWEB) April 28, 2015 ... FDA-approved modular system for two-stage revision of infected ... REMEDY® Spacer is sterile-packaged as a pre-formed, pre-loaded ... elution to the infected joint space. Combined ... articulating surfaces, the REMEDY® spacer is approved for ...
(Date:4/28/2015)... Saint Louis, MO (PRWEB) April 28, 2015 ... May 6, 2015 from 5:00 to 8:00 pm at the ... 01880. More than 50 hospitals, clinics and groups with career ... will be represented. Attendees will enjoy free hors d’oeuvres and ... for PracticeMatch says “Boston is an ideal location ...
Breaking Medicine News(10 mins):Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 2Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 3Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 4Health News:Why Do Some Good Women and Men End Up Breaking Others' Marriages? 2Health News:Why Do Some Good Women and Men End Up Breaking Others' Marriages? 3Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 2Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 3Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 4Health News:PracticeMatch to Host Physician Career Fair at Sheraton Colonial Boston North Hotel on May 6, 2015 2Health News:PracticeMatch to Host Physician Career Fair at Sheraton Colonial Boston North Hotel on May 6, 2015 3
... with mild cognitive impairment revealed that results from cognitive ... warning system for the subsequent development of Alzheimer,s disease. ... the study with mild cognitive impairment, those with low ... metabolism in particular brain regions, as detected through positron ...
... ... is, at Kirkland Uncorked a festival of art, style and taste July 17-19 in Marina Park. ... Kirkland, WA (Vocus) June 26, 2009 ... that is, at Kirkland Uncorked a festival of art, style and taste July 17-19 ...
... nearly two-decade effort to,treat people living with HIV ... the epidemic. Inexpensive generic medicines are a large,part ... and the Harvard,School of Public Health., Brazil did ... prompted pharmaceutical companies with exclusive drugs to,lower their ...
... N.C. Simulating medical scenarios helps medical students learn ... done by researchers at Wake Forest University School of ... Teacher , shows that medical students not only enjoy ... Michael T. Fitch, M.D., Ph.D., the senior author of ...
... Integrate Primary and Specialty Care to Improve the Quality ... of commentaries to understand health and healthcare, With the ... Annals of Family Medicine editor Kurt Stange, M.D., ... help make sense of the problems and opportunities we ...
... , DENVER, July 13 DaVita Inc. ... for those diagnosed with chronic kidney disease (CKD), today announced Mahesh Krishnan, ... for Research, effective July 13, 2009. , , ... DaVita Clinical Research is recognized as a leader in clinical trials for ...
Cached Medicine News:Health News:Memory test and PET scans detect early signs of Alzheimer's 2Health News:Memory test and PET scans detect early signs of Alzheimer's 3Health News:Drinking Wine Is Good For The "Heart" & Environment 2Health News:Brazil proves developing countries can use generic medicines to fight HIV/AIDS epidemic 2Health News:Brazil proves developing countries can use generic medicines to fight HIV/AIDS epidemic 3Health News:Simulating medical situations helps students learn, retain basic science concepts 2Health News:July/August 2009 Annals of Family Medicine tip sheet 2Health News:July/August 2009 Annals of Family Medicine tip sheet 3Health News:July/August 2009 Annals of Family Medicine tip sheet 4Health News:July/August 2009 Annals of Family Medicine tip sheet 5Health News:July/August 2009 Annals of Family Medicine tip sheet 6Health News:July/August 2009 Annals of Family Medicine tip sheet 7Health News:DaVita Clinical Research Appoints Mahesh Krishnan as Vice President 2Health News:DaVita Clinical Research Appoints Mahesh Krishnan as Vice President 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: